FIGURE

Figure 2

ID

ZDB-FIG-200125-41

Publication

Nishiya et al., 2019 - Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling

Other Figures

All Figure Page

Back to All Figure Page

Figure 2

Bucillamine, an antirheumatic drug, suppressed afatinib-induced extra lateral line neuromast development. (a) Structures of the test compound, acrolein, and MESNA are shown. (b) Clinically available sulfhydryl compounds were evaluated for afatinib quenchers. Neuromasts of 72 hpf larvae treated with the indicated test compound were detected by fluorescence of cldnb:gfp. Scale bar = 500 µm. (c) The number of neuromasts on one side were counted. The graph indicates the mean ± SD (n = at least 4). * p < 0.01; MESNA, sodium 2-mercaptoethanesulfonate; hpf, hours postfertilization; SD, standard deviation.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceuticals (Basel)